Table 2 Univariate and multivariate analysis of baseline characteristics with HCC development
Univariant analysis | p-value | Multivariant analysis | p-value | |
|---|---|---|---|---|
HR (95% CI) | HR (95% CI) | |||
Age | 1.00 (0.99–1.01) | NS | ||
Gender:male/female | 3.11 (0.99–9.72) | NS | ||
Child-Pugh score: A/B | 0.48 (0.21–1.10) | NS | ||
ADV-containing/Non-ADV-treatment | 0.18 (0.09–0.43) | < 0.05 | 0.18 (0.07–0.45) | < 0.05 |
Total bilirubin: < 24/≥ 24 (μmol/L) | 0.52 (0.19–1.41) | NS | ||
HBV DNA: < 4/≥ 4 (log10 copies/mL) | 0.85 (0.41–1.76) | NS | ||
HBeAg: Positive/negative | 1.16 (0.54–2.50) | NS |